Cargando…

Naltrexone during pain conditioning: A double-blind placebo-controlled experimental trial

Naltrexone reversibly blocks the effects of opioids and has been shown to decrease placebo analgesia. However, it is not clear (1) to what extent naltrexone affects pain modulation in a nontreatment context, for example, in response to pain cues or (2) how naltrexone given prior to pain-cue learning...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pontén, Moa, Fust, Jens, Kosek, Eva, Guterstam, Joar, Jensen, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297482/ https://www.ncbi.nlm.nih.gov/pubmed/32538267 http://dx.doi.org/10.1177/1744806920927625

Ejemplares similares

Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain: A Systematic Review and Meta-analysis
por: Gedin, Filip, et al.
Publicado: (2022)

Shaping placebo analgesic responses on the Internet: a randomized experimental trial
por: Pontén, Moa, et al.
Publicado: (2019)

Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial
por: Bruun, Karin Due, et al.
Publicado: (2021)

The pain alarm response - an example of how conscious awareness shapes pain perception
por: Pontén, Moa, et al.
Publicado: (2019)

Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
por: Farahmand, S, et al.
Publicado: (2010)

Augmented pain inhibition and higher integration of pain modulatory brain networks in women with self-injury behavior
por: Lalouni, Maria, et al.
Publicado: (2022)

Naltrexone treatment for prolonged grief disorder: study protocol for a randomized, triple-blinded, placebo-controlled trial
por: Gang, James, et al.
Publicado: (2021)

Efficacy of mecobalamin (vitamin B(12)) in the treatment of long-term pain in women diagnosed with fibromyalgia: protocol for a randomised, placebo-controlled trial
por: Sall Hansson, Karin, et al.
Publicado: (2023)

Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial
por: Konstenius, Maija, et al.
Publicado: (2014)

Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial
por: Tek, Cenk, et al.
Publicado: (2013)

Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-analysis
por: Stridh, Alexander, et al.
Publicado: (2020)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
por: Paulides, Emma, et al.
Publicado: (2022)

A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder
por: Plank, Julia R., et al.
Publicado: (2022)

Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study
por: Jayaram-Lindström, N, et al.
Publicado: (2017)

Predicting pain: differential pain thresholds during self-induced, externally induced, and imagined self-induced pressure pain
por: Lalouni, Maria, et al.
Publicado: (2021)

Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial
por: Paula, Tânia Maria Hendges de, et al.
Publicado: (2022)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
por: Colquhoun, Ross M.
Publicado: (2013)

Low-dose naltrexone’s utility for non-cancer centralized pain conditions: a scoping review
por: Rupp, Adam, et al.
Publicado: (2023)

Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study
por: Vicknasingam, Balasingam, et al.
Publicado: (2020)

Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)
por: Colomer-Carbonell, Ariadna, et al.
Publicado: (2022)

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
por: Attarian, Shahram, et al.
Publicado: (2014)

A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Lysinate in Comparison to Ibuprofen Acid for Acute Postoperative Dental Pain
por: Kyselovič, Ján, et al.
Publicado: (2020)

Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
por: Hansen, Julie Schjødtz, et al.
Publicado: (2023)

Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)
por: Morley, Kirsten C., et al.
Publicado: (2018)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

3494 Naltrexone as a Diagnostic Tool in Ocular Neuropathic Pain
por: Fowler, Nicholas, et al.
Publicado: (2019)

Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial
por: Levy-Schousboe, Karin, et al.
Publicado: (2021)

Neural correlates of conditioned pain responses in fibromyalgia subjects indicate preferential formation of new pain associations rather than extinction of irrelevant ones
por: Sandström, Angelica, et al.
Publicado: (2020)

The effect of Neuragen PN(® )on Neuropathic pain: A randomized, double blind, placebo controlled clinical trial
por: Li, Li
Publicado: (2010)

Randomized, Double‐Blind, Placebo‐Controlled Trial of Intraarticular Trans‐Capsaicin for Pain Associated With Osteoarthritis of the Knee
por: Stevens, Randall M., et al.
Publicado: (2019)

Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
por: Söderman, Lisa, et al.
Publicado: (2021)

O-Benzoylnaltrexone
por: Yang, Rui, et al.
Publicado: (2013)

Asymmetric synthesis of (–)-naltrexone
por: Dongbang, Sun, et al.
Publicado: (2018)

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
por: Attarian, Shahram, et al.
Publicado: (2016)

Effect of pretreatment medication on postendodontic pain: A double-blind, placebo-controlled study
por: Konagala, Ravi Kumar, et al.
Publicado: (2019)

A double blind, randomised placebo controlled trial of topical 2% viscous lidocaine in improving oral intake in children with painful infectious mouth conditions
por: Hopper, Sandy M, et al.
Publicado: (2011)

Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2022)

ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder–Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial
por: Zimmermann, Sina, et al.
Publicado: (2022)

Adjuvant use of melatonin for pain management in endometriosis-associated pelvic pain—A randomized double-blinded, placebo-controlled trial
por: Söderman, Lisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rda12qnh65pn1dlp5nuadr4o3u